Nanrilkefusp alfa is a human fusion protein consisting of the cytokine interleukin (IL)-15 and the high-affinity binding sushi+ domain of IL-15 receptor alpha (IL-15Ra).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.